Stockreport

Crispr stock up 8% as company says FDA accepted new-drug application [MarketWatch]

News Corporation - Class B  (NWS) 
US:NASDAQ Investor Relations: investors.newscorp.com/investor-relations
PDF Crispr stock up 8% as company says FDA accepted new-drug application Shares of Crispr Therapeutics AG CRSP, -0.57% rose more than 8% in the extended session Wednesday [Read more]